Sign in Subscribe
Communicable diseases

Truncated Hepatitis C Virus Core Protein Encoded in Hepatocellular Carcinomas

Strategic Insights

— 2 min read

Research conducted in the United States has found that a truncated form of the hepatitis C virus (HCV) core protein may play a role in the development of hepatocellular carcinomas (HCC). Studies have suggested that this truncated protein can enter hepatocyte nuclei, and mutations in the HCV core gene that encode it have been detected in four out of eight patients with HCC. R. Yamaguchi and collaborators from the U.S. Food and Drug Administration discovered these mutated sequences in the HCC patients, suggesting that they may have contributed to the development of these carcinomas.

Key Takeaways:

  • Four out of eight patients with hepatocellular carcinomas (HCC) had mutated HCV core genes that encoded a truncated core protein.
  • The truncated core protein can enter hepatocyte nuclei, unlike the full-length HCV protein, which is exclusively cytoplasmic.
  • R. Yamaguchi and collaborators from the U.S. Food and Drug Administration detected mutated sequences encoding the truncated core protein in HCC patients.
  • These mutations may have played a role in the development of hepatocellular carcinomas in the four patients with mutated HCV core genes.
  • Y. Zhong and S. J. Gao have also demonstrated that a truncated form of the HCV core protein can induce apoptosis in human liver cells.
  • The detection of truncated HCV core protein in hepatocellular carcinomas suggests a potential new target for therapy in the treatment of HCC.
  • The findings of this study provide further evidence that HCV infection is a major risk factor for the development of hepatocellular carcinoma.
  • R. Yamaguchi and collaborators suggest that the detection of mutated HCV core genes in HCC patients could be used as a diagnostic tool for the detection of HCV-associated carcinomas.
  • The study was published by R. Yamaguchi and collaborators in the International Journal of Molecular Medicine in 2004.

Statistics:

  • Four out of eight (50%) patients with HCC had mutated HCV core genes.
  • The truncated HCV core protein was detected in hepatocyte nuclei, which is unlike the full-length HCV protein.
  • The study was conducted in eight patients with HCC and/or adjacent nontumorous liver tissues.
  • The mutated sequences encoding the truncated core protein were found in four of the eight patients (50%).
  • The HCC patients with mutated HCV core genes may have developed their carcinomas due to the presence of the truncated core protein.

Sources:

  • Yamaguchi, R., et al. (2004). Truncated hepatitis C virus core protein encoded in hepatocellular carcinomas. International Journal of Molecular Medicine, 14(6), 1097-1100.
  • Health & Medicine Week (2005). Truncated hepatitis C virus core protein encoded in hepatocellular carcinomas. NewsRx.com & NewsRx.net.

Read more